Innovation in the Swiss pharmaceutical industry | Severin Schwan | Innoscape Talk #1

Is Switzerland losing its position among the world’s leading locations for R&D? Our first Innoscape Talk is dedicated to the topic of innovation in the Swiss pharmaceutical industry. Severin Schwan (CEO Roche) explains his views about current developments in the Swiss life sciences sector and shares his experiences on how to accelerate innovation within a corporation. Questions: 00:00 Intro 00:24 How can a corporation enhance innovation activity? 02:04 Does the approach to innovation vary between different R&D locations of Roche? 05:38 What are the strengths of Switzerland as a location for R&D? 07:09 How and why does Roche collaborate with academia? 08:09 What challenges does Switzerland face as a location for R&D? 12:29 What are the consequences of a sluggish digitalization in the Swiss Health Sector? 15:22 What can Switzerland learn from the USA in terms of digitalization in the Health Sector? 18:14 What policies should the Swiss government pursue to promote innovation? 20:41 How did Covid-19 change the pharmaceutical industry? 24:32 Outro Innoscape Talks is an online interview video series embedded in the Innoscape Project. Leading experts from industry, politics and academia exclusively share their knowledge and experiences related to specific aspects of innovation. We want to contribute to a broad public discussion about the viability of Switzerland’s current innovation landscape. For more information check out our website and follow us on social media: https://innoscape.ch https://cieb.unibas.ch   / cieb_unibas     / cieb-unibas   Center for International Economics and Business | CIEB University of Basel